
UnitedHealth Group (UNH) updated its 2025 outlook, reinstating guidance for revenues of $445.5 billion to $448.0 billion and adjusted earnings of at least $16.00 per share, with a return to earnings growth anticipated in 2026. This follows the company's Q2 results, which reported adjusted earnings per share of $4.08, significantly missing analyst expectations of $4.45 and down sharply from $6.80 year-over-year, despite a 12.9% revenue increase to $111.616 billion. Consequently, UNH shares declined 3% in pre-market trading.
UnitedHealth Group's second-quarter results reveal a significant profitability challenge, with adjusted earnings per share of $4.08 falling well short of the $4.45 analyst consensus and marking a sharp decline from $6.80 in the prior year. This earnings miss, which triggered a 3% pre-market share price drop, occurred despite a robust 12.9% year-over-year revenue increase to $111.616 billion, indicating that margin pressure is the primary concern. In a move to restore clarity, the company reinstated its 2025 guidance, projecting revenues of $445.5 billion to $448.0 billion and an adjusted EPS of at least $16.00. Management is framing the current issues as temporary by explicitly forecasting a return to earnings growth in 2026, suggesting a challenging 2025 followed by a recovery.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment